Completed NA INTERVENTIONAL 2-arm NCT00654888

Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy (ALKSBK)

Study of Automated Lamellar Keratectomy With a New Option in Treatment in Symptomatic Patients With Bullous Keratopathy.

Sponsor: Federal University of São Paulo

Conditions Corneal Disease

Interventions ALK (automated lamellar keratectomy) Mitomycin

Updated 5 times since 2017 Last updated: Apr 10, 2008 Started: Mar 31, 2005 Primary completion: Mar 31, 2006 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Corneal Disease and is currently completed. Federal University of São Paulo leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal University of São Paulo

Data source: Federal University of São Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.